BPH Global Ltd (BP8) - Total Assets
Based on the latest financial reports, BPH Global Ltd (BP8) holds total assets worth AU$541.00K AUD (≈ $382.79K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See BPH Global Ltd shareholders equity for net asset value and shareholders' equity analysis.
BPH Global Ltd - Total Assets Trend (1999–2025)
This chart illustrates how BPH Global Ltd's total assets have evolved over time, based on quarterly financial data.
BPH Global Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
BPH Global Ltd's total assets of AU$541.00K consist of 99.6% current assets and 0.4% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 28.2% |
| Accounts Receivable | AU$211.09K | 39.0% |
| Inventory | AU$138.80K | 25.7% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (1999–2025)
This chart illustrates how BPH Global Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BPH Global Ltd market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BPH Global Ltd's current assets represent 99.6% of total assets in 2025, an increase from 34.1% in 1999.
- Cash Position: Cash and equivalents constituted 28.2% of total assets in 2025, up from 16.1% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 19.0% in 1999.
- Asset Diversification: The largest asset category is accounts receivable at 39.0% of total assets.
BPH Global Ltd Competitors by Total Assets
Key competitors of BPH Global Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yabao Pharmaceutical Group Co Ltd
SHG:600351
|
China | CN¥3.34 Billion |
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF21.61 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.22 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
BPH Global Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.27 | 0.18 | 3.48 |
| Quick Ratio | 0.20 | 0.15 | 3.48 |
| Cash Ratio | 0.00 | 0.00 | 3.43 |
| Working Capital | AU$-1.47 Million | AU$-1.41 Million | AU$626.05K |
BPH Global Ltd - Advanced Valuation Insights
This section examines the relationship between BPH Global Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.63 |
| Latest Market Cap to Assets Ratio | 4.85 |
| Asset Growth Rate (YoY) | -21.8% |
| Total Assets | AU$541.00K |
| Market Capitalization | $2.62 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values BPH Global Ltd's assets at a significant premium (4.85x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: BPH Global Ltd's assets decreased by 21.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BPH Global Ltd (1999–2025)
The table below shows the annual total assets of BPH Global Ltd from 1999 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$541.00K ≈ $382.79K |
-21.80% |
| 2024-06-30 | AU$691.84K ≈ $489.52K |
-67.11% |
| 2023-06-30 | AU$2.10 Million ≈ $1.49 Million |
-72.41% |
| 2022-06-30 | AU$7.62 Million ≈ $5.39 Million |
-17.40% |
| 2021-06-30 | AU$9.23 Million ≈ $6.53 Million |
+811.65% |
| 2020-06-30 | AU$1.01 Million ≈ $716.46K |
-58.36% |
| 2019-06-30 | AU$2.43 Million ≈ $1.72 Million |
+53.73% |
| 2018-06-30 | AU$1.58 Million ≈ $1.12 Million |
-39.93% |
| 2017-06-30 | AU$2.63 Million ≈ $1.86 Million |
-46.06% |
| 2016-06-30 | AU$4.88 Million ≈ $3.45 Million |
+36.32% |
| 2015-06-30 | AU$3.58 Million ≈ $2.53 Million |
+16865.99% |
| 2014-06-30 | AU$21.11K ≈ $14.93K |
-99.99% |
| 2007-06-30 | AU$280.75 Million ≈ $198.65 Million |
+36.34% |
| 2006-06-30 | AU$205.93 Million ≈ $145.71 Million |
+49.21% |
| 2005-06-30 | AU$138.01 Million ≈ $97.65 Million |
+71.47% |
| 2004-06-30 | AU$80.48 Million ≈ $56.95 Million |
+112.85% |
| 2003-06-30 | AU$37.81 Million ≈ $26.75 Million |
+114.37% |
| 2002-06-30 | AU$17.64 Million ≈ $12.48 Million |
-0.12% |
| 2001-06-30 | AU$17.66 Million ≈ $12.50 Million |
+34.75% |
| 2000-06-30 | AU$13.11 Million ≈ $9.27 Million |
+8.86% |
| 1999-06-30 | AU$12.04 Million ≈ $8.52 Million |
-- |
About BPH Global Ltd
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics… Read more